HOME >> MEDICINE >> NEWS
UCLA Nobel Laureate honored with membership in the American Philosophical Society

Louis J. Ignarro, Ph.D. (Beverly Hills, Calif.), distinguished professor of pharmacology at the David Geffen School of Medicine at UCLA and winner of the 1998 Nobel Prize in medicine, has been elected to the American Philosophical Society.

Founded in 1743 by Benjamin Franklin, the American Philosophical Society is the countrys oldest learned society, recognizing extraordinary achievements in science, letters and the arts. Ignarro joins an illustrious group of members that has included Charles Darwin, Marie Curie, Albert Einstein, Andrew Carnegie and Beverly Sills.

The American Philosophical Society promotes knowledge through scholarly research, professional meetings, publications, library resources and community outreach. Currently, there are 900 members.

Ignarros groundbreaking discovery of the importance of nitric oxide in cardiovascular health secured him the 1998 Nobel Prize. He found that nitric oxide is produced in the blood vessels and controls the flow of blood by signaling vessels to expand and contract. A shortage in nitric oxide production, caused by poor diet and lack of physical activity, can lead to cardiovascular disease including heart attack, stroke and high cholesterol.

Ignarro also discovered that nitric oxide is the neurotransmitter responsible for penile erection, which led to the development of Viagra, the first oral medication for the treatment of erectile dysfunction.

Additional prestigious awards Ignarro has received include the Basic Research Prize of the American Heart Association, the CIBA Award for Hypertension Research and the Roussel Uclaf Prize for Cell Communication and Signaling. He has been elected to the National Academy of Sciences and the American Academy of Arts and Sciences and has published more than 500 articles. Ignarro, who has been at UCLA for 22 years, is currently a professor of molecular and medical pharmacology at the David Geffen School of Medicine
'"/>

Contact: Rachel Champeau
rchampeau@mednet.ucla.edu
310-794-0777
University of California - Los Angeles
18-May-2007


Page: 1 2

Related medicine news :

1. New research says winning a Nobel Prize adds nearly two years to your lifespan
2. Nobel Laureate keynote speaker at conference on nanomedicine, geriatric care, brain injury
3. Nobel Laureates featured in symposium in honor of new research center at NYU School of Medicine
4. Nobel Laureate Eric Kandel condemns censorship of scientists
5. Nobel Laureate Eric Kandel to discuss the New Science of the Mind
6. Researchers win Nobel Medicine Prize for discovering cause of ulcers
7. Heroes of Chemistry honored for medical, energy, environmental breakthroughs
8. UCLA pediatrician honored with prestigious achievement award
9. UQ researchers honored with leading fellowships
10. U of M faculty honored by US FDA for contributions to national food safety and defense
11. UCLA surgeon honored with American Association for Thoracic Surgerys Achievement Award

Post Your Comments:
(Date:10/30/2014)... of data from an institutional patient registry on ... control, 79 percent of tumors, for medically inoperable, ... from 2003 to 2012, according to research presented ... Thoracic Oncology. The Symposium is sponsored by the ... Society for Radiation Oncology (ASTRO), the International Association ...
(Date:10/30/2014)... WHAT: , A mathematical model developed by NIH grantees ... daily to prevent HIV infection via vaginal sex, whereas ... HIV infection via anal sex. This finding helps explain ... or PrEP, in women failed to show efficacy. Participants ... trials of Truvada and tenofovir (another antiretroviral) for HIV ...
(Date:10/30/2014)... Graphics, coding, typography and search engine optimization– ... of web design and require thorough knowledge to create ... to create a website can be as easy as ... reviews and Facebook posts all accumulate on a multiple ... evolution of how a business can develop a website," ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 Five months ... Hodgkinson Street LLC announces new branding and a ... Street Mepham . After David Mepham’s promotion to name ... brand and website to include Mepham’s name and better ... malpractice and mediation firm, the decision to implement new ...
(Date:10/30/2014)... 2014 Radio listeners who indicate use ... the impact of traditional radio commercials and have overwhelmingly ... to influence a purchasing decision. , Those are some ... conducted by radio marketing company CRN International. The research ... results of respondents who indicated they have purchased or ...
Breaking Medicine News(10 mins):Health News:Sustained local control for medically inoperable, early stage lung cancer patients 2Health News:Sustained local control for medically inoperable, early stage lung cancer patients 3Health News:Model by NIH grantees explains why HIV prevention dosing differs by sex 2Health News:Facebook Websites In Thirty-Seconds 2Health News:Hodgkinson Street Mepham Rebrands 2Health News:CRN Research On Radio Messaging Effectiveness Now Available In Four Specific Product Categories 2Health News:CRN Research On Radio Messaging Effectiveness Now Available In Four Specific Product Categories 3
(Date:10/30/2014)... 2014   ViaDerma, Inc. (OTCQB: VDRM), ... products to market, has recently released a revolutionary ... a topical liquid tetracycline-based antibiotic that uses a ... oral medication active ingredients into topical drugs. The ... antibiotic to help prevent skin infection in minor ...
(Date:10/30/2014)... CVS Health (NYSE: CVS ) announced ... leading regional health systems to enhance access to high-quality, affordable ... Baptist Health System in Alabama ; Community ... Pennsylvania , Northwest Medical Center, including Oro ... Healthcare in Tennessee ; and Premier Health ...
(Date:10/30/2014)... Kingdom , Oct. 30, 2014 Molecular ... CBRX ) and Maryland ... developers with improved efficiency during clinical development that will ... next week. This partnership extends ... platform, which it launched earlier this month. The company ...
Breaking Medicine Technology:ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 3CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 2CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 3CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 4Molecular Profiles To Launch US Strategic Alliance At AAPS 2Molecular Profiles To Launch US Strategic Alliance At AAPS 3
Cached News: